Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study
Dermatitis® · 01.06.2023 · 34 (3) · 241-249
DOI: 10.1089/derm.2022.0094 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Dermatitis®, online erschienen am 17.05.2023. Verfasst von Shou-En Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Herpes Zoster, Biological Products. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Background
In the wake of the emerging development of biologics in atopic dermatitis (AD), herpes zoster (HZ) infection has been reported as a treatment-related adverse event.
Objectives
This study aims at investigating the association between AD and HZ, and the risk factors within.
Methods
28,677 participants with AD from the Taiwan National Health Insurance Research Database 2000–2015 were enrolled. Risk of HZ infection was compared in the study cohort (with AD) and the control cohort (without AD). Further analyses were conducted in gender-, age-, and treatment strategy-stratified subgroups.
Results
Significantly higher adjusted hazard ratios (aHRs) of HZ infection were revealed in AD patients (aHR = 2.303, P < 0.001), and remained this trend in gender- and age-stratified models. All AD groups, irrespective of the treatment type, had higher aHRs (AD without systemic treatment: aHR = 2.356, P < 0.001; AD with systemic treatment: aHR = 2.182, P < 0.001) compared with those without AD. However, no differences in HZ risk were shown between each treatment type.
Conclusions
Risk of HZ infection in AD is higher irrespective of treatment type. Considering that AD per se increases susceptibility to HZ infection, the administration of biologics requires careful considerations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
- School of Public Health, National Defense Medical Center, Taipei, Taiwan.
- Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
- Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan.
- Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan.
- Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
ORCID-Profile: Chih-Tsung Hung
Zitieren
APA
Wu, S. E., Chen, Y. H., Chung, C. H., Wu, G. J., Tsao, C. H., Sun, C. A., Chien, W. C., & Hung, C. T. (2023). Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study. Dermatitis®, 34(3), 241-249. https://doi.org/10.1089/derm.2022.0094
Vancouver
Wu SE, Chen YH, Chung CH, Wu GJ, Tsao CH, Sun CA, et al. Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study. Dermatitis®. 2023;34(3):241-249. doi:10.1089/derm.2022.0094
BibTeX
@article{Wu2023,
author = {Wu, Shou-En and Chen, Yi-Hsien and Chung, Chi-Hsiang and Wu, Gwo-Jang and Tsao, Chang-Huei and Sun, Chien-An and Chien, Wu-Chien and Hung, Chih-Tsung},
title = {Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study},
journal = {Dermatitis®},
year = {2023},
volume = {34},
number = {3},
pages = {241--249},
doi = {10.1089/derm.2022.0094}
}
EUVIMED